Anticoagulation in patients with atrial fibrillation and chronic kidney disease: clinical complexity beyond thromboembolism

Intern Emerg Med. 2024 Oct;19(7):1797-1799. doi: 10.1007/s11739-024-03733-1. Epub 2024 Aug 3.

Authors

Giovanni Buoninfante¹, Stefania Basili¹, Giulio Francesco Romiti^{2

3}

Affiliations

¹ Department of Translational and Precision Medicine, Sapienza - University of Rome, Rome, Italy.
² Department of Translational and Precision Medicine, Sapienza - University of Rome, Rome, Italy. giuliofrancesco.romiti@uniroma1.it.
³ Liverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool John Moores University and Liverpool Heart and Chest Hospital, Liverpool, UK. giuliofrancesco.romiti@uniroma1.it.

PMID: 39096349
DOI: 10.1007/s11739-024-03733-1

No abstract available

Publication types

Editorial

MeSH terms

Anticoagulants* / therapeutic use
Atrial Fibrillation* / complications
Atrial Fibrillation* / drug therapy
Humans
Renal Insufficiency, Chronic* / complications
Thromboembolism* / drug therapy
Thromboembolism* / prevention & control

Substances

Anticoagulants